Dianthus Therapeutics | MGTA - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
Akebia Therapeutics USD 43.82M 16.98M 2025-03
Alaunos Therapeutics USD 1.19M 428K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Celltrion KRW 724.99B 6B 2025-09
Cspc Pharmaceutical CNY 5.4B 298.41M 2025-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 40.68M 5.56M 2025-09
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 118.61M 11.79M 2025-09
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 1.54B 259M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organigram Holdings CAD 108.11M 17.03M 2025-09
Organon & Co USD 906M 362M 2025-09
Ovoca Bio EUR 5.65M 3.45M 2022-06
Pharma Mar EUR 46.87M 7.24M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Sartorius EUR 693.1M 29.4M 2025-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 21.89M 440K 2025-09
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 67.65M 590K 2025-09
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09